Oncology Institute (TOI) 10% Owner Chernett Jorey Buys 18,000 Shares

What Happened

• Chernett Jorey, listed as a 10% owner of Oncology Institute, Inc. (TOI), purchased 18,000 shares of TOI in an open-market/private purchase on July 21, 2026. The reported weighted-average price was $5.27 per share, for a total transaction value of approximately $94,860. This is a purchase (a cash outflow by the insider), which many investors treat as a potentially bullish signal, though it does not prove future performance.

Key Details

• Transaction date: 2026-07-21 (reported in Form 4 filed 2026-07-22) — filing appears timely.
• Transaction type/code: P = Purchase (open market/private purchase).
• Shares bought: 18,000 at a weighted-average price of $5.27; total ≈ $94,860.
• Price range: shares were acquired in multiple trades at prices ranging $5.27–$5.28 (rounded); the $5.27 figure is a weighted average per the filing (footnote F1).
• Shares owned after transaction: not specified in the information provided in your summary (check the full Form 4 for post-transaction holdings).
• Footnote: Mr. Chernett offers to provide the issuer, any security holder, or the SEC staff, upon request, the breakdown of the number of shares bought at each separate price.

Context

• As a 10% owner, Chernett Jorey is a significant shareholder; such trades reflect activity by a major stakeholder rather than routine employee compensation transactions. Purchases by large shareholders can be meaningful to retail investors, but they should be considered alongside other factors (company fundamentals, market conditions). The filing shows a straightforward purchase—no derivative exercise, gift, or tax-withholding action is reported.